Malonyl CoA Decarboxylase Inhibition Improves Cardiac Function Post-Myocardial Infarction-Reference-Cited by-同舟云学术

Malonyl CoA Decarboxylase Inhibition Improves Cardiac Function Post-Myocardial Infarction

Published:2019-06 Issue:3 Volume:4 Page:385-400
ISSN:2452-302X
Container-title:JACC: Basic to Translational Science
language:en
Short-container-title:JACC: Basic to Translational Science

Author:

Wang Wei,Zhang Liyan,Battiprolu Pavan K.,Fukushima Arata,Nguyen Khanh,Milner Kenneth,Gupta Abhishek,Altamimi Tariq,Byrne Nikole,Mori Jun,Alrob Osama Abo,Wagg Cory,Fillmore Natasha,Wang Shao-hua,Liu Dongming M.,Fu Angela,Lu Jenny Yinglin,Chaves Mary,Motani Alykhan,Ussher John R.,Reagan Jeff D.,Dyck Jason R.B.,Lopaschuk Gary D.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference39 articles.

1. Cardiovascular remodelling in coronary artery disease and heart failure;Heusch;Lancet,2014

2. Myocardial fatty acid metabolism in health and disease;Lopaschuk;Physiol Rev,2010

3. Mitochondrial energy metabolism in heart failure: a question of balance;Huss;J Clin Invest,2005

4. Agonist-induced hypertrophy and diastolic dysfunction are associated with selective reduction in glucose oxidation: a metabolic contribution to heart failure with normal ejection fraction;Mori;Circ Heart Fail,2012

5. Pressure-overload-induced heart failure induces a selective reduction in glucose oxidation at physiological afterload;Zhabyeyev;Cardiovasc Res,2013

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondrial inhibitors: a new horizon in breast cancer therapy;Frontiers in Pharmacology;2024-07-04

2. Metabolic Flexibility of the Heart: The Role of Fatty Acid Metabolism in Health, Heart Failure, and Cardiometabolic Diseases;International Journal of Molecular Sciences;2024-01-19

3. KUS121, a VCP modulator, has an ameliorating effect on acute and chronic heart failure without calcium loading via maintenance of intracellular ATP levels;Biomedicine & Pharmacotherapy;2024-01

4. Effects of Fatty Acid Metabolism on Heart Failure;Advances in Clinical Medicine;2024

5. A gene therapy targeting medium-chain acyl-CoA dehydrogenase (MCAD) did not protect against diabetes-induced cardiac pathology;Journal of Molecular Medicine;2023-11-21